Journal of Cardiovascular Pharmacology

Aims & Scope

Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology.

The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke, kidney disease, lipid disorders, diabetes, systemic and pulmonary hypertension, cancer angiogenesis, neural and hormonal control of the circulation, sepsis, neurodegenerative diseases with a vascular component, cardiac and vascular remodeling, heart failure, angina, anticoagulants/antiplatelet agents, drugs/agents that affect vascular smooth muscle, and arrhythmias.

Appropriate subjects include new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects, application of drugs to gain novel insights into physiology or pathological conditions, clinical results with new and established agents, and novel methods.

The focus is on pharmacology in its broadest applications, incorporating not only traditional approaches, but new approaches to the development of pharmacological agents and the prevention and treatment of cardiovascular diseases.

Please note that JCVP does not publish work based on biological extracts of mixed and uncertain chemical composition or unknown concentration.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.2
2024	2.60

Journal Rank

Year	Value
2024	8332

Journal Citation Indicator

Year	Value
2024	1230

SJR (SCImago Journal Rank)

Year	Value
2024	0.684

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	111

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Nitric Oxide as a Signaling Molecule in the Vascular System: An Overview

  Citation: 583

  Authors: Louis J., Giuseppe, Alessandro, Claudio

• Energy Metabolic Phenotype of the Cardiomyocyte During Development, Differentiation, and Postnatal Maturation

  Citation: 567

  Authors: Gary D, Jagdip S

• The Importance of the Hyperpolarizing Mechanism Increases as the Vessel Size Decreases in Endothelium-Dependent Relaxations in Rat Mesenteric Circulation

  Citation: 549

  Authors: Hiroaki, Hiroshi, Koji, M. Koji, Ryuichi, Yoshihiro, Tsuneo, Tetsuhiko, Kensuke, Masatoshi, Akira

• Fibroblasts and Myofibroblasts: What Are We Talking About?

  Citation: 405

  Authors: Jennifer, Heather S

• The Biochemical Pathways of Nitric Oxide Formation from Nitrovasodilators

  Citation: 391

  Authors: M.

• The Role of Endothelium in Cardiovascular Homeostasis and Diseases

  Citation: 380

  Authors: Gabor M.

• Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis

  Citation: 361

  Authors: Patrick, Anna, Alison, Joe, Salvador

• The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551)

  Citation: 356

  Authors: Andrew J., Sharon E., J. Desmond, Janet L.

• High-carbohydrate High-fat Diet–induced Metabolic Syndrome and Cardiovascular Remodeling in Rats

  Citation: 343

  Authors: Sunil K, Hemant, Abishek, Reeza, Ashraful, Vishal, Kathleen, Conrad, Fiona, Leigh, Glenda, Andrew, Lindsay

• Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury

  Citation: 326

  Authors: Peter, Martina, Axel, Wolfram, Elke, Lars, Frank, Barbara, Stefan

---